+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Matrix metalloproteinase (MMP-9) in patients with rheumatoid arthritis



Matrix metalloproteinase (MMP-9) in patients with rheumatoid arthritis



Ryumachi 35(5): 792-801



MMP-9 degrades type IV collagen, gelatin, type V collagen, and type XI collagen. We measured proMMP-9 and proMMP-9/TIMP-1 complex in sera and joint fluids by sandwich ELISA, and examined immunohistochemically the expression of these proteins in joint tissue from patients with rheumatoid arthritis (RA). ProMMP-9 was purified by the three chromatographic steps from the culture medium of HT1080 cells. Purified proMMP-9 and activated MMP-9 by APMA showed a single band of Mr92000, Mr67000, resectively on gelatin-zymography. We raised two monoclonal antibody colones 2G9, 8G7 against proMMP-9 with BALB/c mice. 2G9 and 8G7 reacted with proMMP-9 on Western blotting, and these clones reacted proMMP-9 and proMMP-9/TIMP-1 complex on sandwich ELISA, specifically. ProMMP-9 concentration in 86 sera (749.4+/-940.2 ng/ml) and 54 joint fluids (4539.9+/-7681.5 ng/ml) from patients with RA was significantly higher than those of patients with osteoarthritis and control. Immunohistochemistry with 2G9 showed that in rheumatoid synovium proMMP-9 localized in neutrophils and monocytes diffusely infiltrated the sublining layer. In addition, osteoclasts in rheumatoid subchondral bone were intensively stained. ProMMP-9 concentration in joint fluids from 39 RA patients was not correlated to stage and class of Steinbrocker and to clinical laboratorial data. But, it was positively correlated to the number of proMMP-9 positive cells in RA synovium (r=0.607) and the score of Roony's diffuse infiltrates of lymphocytes (r=0.720). Our results suggest a role of MMP-9 in joint destraction of RA throughout neutrophils and monocytes, and a regulation of this enzyme by lymphocytes.

(PDF emailed within 1 workday: $29.90)

Accession: 046631153

Download citation: RISBibTeXText

PMID: 8594658


Related references

Reduction of serum matrix metalloproteinase 1 and matrix metalloproteinase 3 in rheumatoid arthritis patients following anti-tumour necrosis factor-alpha (cA2) therapy. British Journal of Rheumatology 36(6): 643-650, 1997

Reduction of serum matrix metalloproteinase 1 and matrix metalloproteinase 3 in rheumatoid arthritis patients following anti- tumour necrosis factor-alpha (cA2) therapy. Rheumatology 36(6): 643-650, 1997

Early joint erosions and serum levels of matrix metalloproteinase 1, matrix metalloproteinase 3, and tissue inhibitor of metalloproteinases 1 in rheumatoid arthritis. Arthritis and Rheumatism 44(10): 2263-2274, 2001

Differential regulation of matrix metalloproteinase 2 and matrix metalloproteinase 9 by activated protein C: relevance to inflammation in rheumatoid arthritis. Arthritis and Rheumatism 56(9): 2864-2874, 2007

Matrix metalloproteinase 9 (MMP-9) in patients with psoriatic arthritis and rheumatoid arthritis. Clinical and Experimental Rheumatology 19(6): 760-760, 2002

Matrix metalloproteinase 9 (MMP-9) in patients with rheumatoid arthritis. Modern Rheumatology 7(3): 197-209, 1997

Dynamics of matrix metalloproteinase (MMP)-13 in the patients with rheumatoid arthritis. Ryumachi 42(1): 60-69, 2002

Adiponectin may contribute to synovitis and joint destruction in rheumatoid arthritis by stimulating vascular endothelial growth factor, matrix metalloproteinase-1, and matrix metalloproteinase-13 expression in fibroblast-like synoviocytes more than proinflammatory mediators. Arthritis Research & Therapy 11(6): R161-R161, 2010

Matrix metalloproteinase gene polymorphisms in patients with rheumatoid arthritis. Rheumatology International 30(3): 369-373, 2010

Possible involvement of matrix metalloproteinase-3 in the pathogenesis of macroprolactinaemia in some patients with rheumatoid arthritis. European Journal of Endocrinology 169(2): 203-209, 2014

Caution is needed when interpreting changes of matrix metalloproteinase-3 in patients with rheumatoid arthritis. Rheumatology International 34(7): 1025-1026, 2015

Value of serum matrix metalloproteinase-3 in the assessment of active disease in patients with rheumatoid arthritis. Zhonghua Yi Xue Za Zhi 95(47): 3823-3828, 2016

Identification of matrix metalloproteinase-9 in the synovial fluid and plasma of patients with rheumatoid arthritis. Arthritis & Rheumatism 36(9 SUPPL ): S56, 1993

The effects of pulse methylprednisolone on matrix metalloproteinase and tissue inhibitor of metalloproteinase-1 expression in rheumatoid arthritis. Rheumatology 39(10): 1067-1073, 2000

AB0231 Elevation of Serum Matrix Metalloproteinase-3 in A Group of Rheumatoid Arthritis Algerian Patients. Annals of the Rheumatic Diseases 73(Suppl 2): 880-880, 2014